Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Griffith

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Infectious Diseases and Therapy|July 10, 2024
Real-World Patients' Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional SurveyKozo Morimoto, Jack R Gallagher, Dirk Wagner, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2016
In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium ComplexBarbara A Brown-Elliott, Julie V Philley, David E Griffith, et al.
American Journal of Respiratory and Critical Care Medicine|April 30, 2005
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung diseaseDavid E Griffith, Barbara A Brown-Elliott, Sara Shepherd, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2014
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infectionsRichard J Wallace, Gary Dukart, Barbara A Brown-Elliott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2009
NKG2D-dependent IL-17 production by human T cells in response to an intracellular pathogenPadmaja Paidipally, Sivakumar Periasamy, Peter F Barnes, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|March 1, 2019
Microbiome Diversity in Sputum of Nontuberculous Mycobacteria Infected Women with a History of Breast CancerJulie V Philley, Anbarasu Kannan, Patti Olusola, et al.
American Journal of Respiratory and Critical Care Medicine|March 4, 2006
Factors related to response to intermittent treatment of Mycobacterium avium complex lung diseasePhung K Lam, David E Griffith, Timothy R Aksamit, et al.
Chest|October 31, 2014
The significance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapyDavid E Griffith, Julie V Philley, Barbara A Brown-Elliott, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 14, 2019
Management and diagnosis of tuberculosis in solid organ transplant candidates and recipients: Expert survey and updated review<sup></sup>Kelly M Pennington, Cassie C Kennedy, Subhash Chandra, et al.
American Journal of Respiratory and Critical Care Medicine|November 17, 2015
Reply: Cure Not Possible, by DefinitionDavid E Griffith, Jennifer Adjemian, Barbara A Brown-Elliott, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Infectious Diseases and Therapy|July 10, 2024
Real-World Patients' Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional SurveyKozo Morimoto, Jack R Gallagher, Dirk Wagner, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2016
In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium ComplexBarbara A Brown-Elliott, Julie V Philley, David E Griffith, et al.
American Journal of Respiratory and Critical Care Medicine|April 30, 2005
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung diseaseDavid E Griffith, Barbara A Brown-Elliott, Sara Shepherd, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2014
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infectionsRichard J Wallace, Gary Dukart, Barbara A Brown-Elliott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2009
NKG2D-dependent IL-17 production by human T cells in response to an intracellular pathogenPadmaja Paidipally, Sivakumar Periasamy, Peter F Barnes, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|March 1, 2019
Microbiome Diversity in Sputum of Nontuberculous Mycobacteria Infected Women with a History of Breast CancerJulie V Philley, Anbarasu Kannan, Patti Olusola, et al.
American Journal of Respiratory and Critical Care Medicine|March 4, 2006
Factors related to response to intermittent treatment of Mycobacterium avium complex lung diseasePhung K Lam, David E Griffith, Timothy R Aksamit, et al.
Chest|October 31, 2014
The significance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapyDavid E Griffith, Julie V Philley, Barbara A Brown-Elliott, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 14, 2019
Management and diagnosis of tuberculosis in solid organ transplant candidates and recipients: Expert survey and updated review<sup></sup>Kelly M Pennington, Cassie C Kennedy, Subhash Chandra, et al.
American Journal of Respiratory and Critical Care Medicine|November 17, 2015
Reply: Cure Not Possible, by DefinitionDavid E Griffith, Jennifer Adjemian, Barbara A Brown-Elliott, et al.
Pageof 12